SCHEMBL15065795

SCHEMBL15065795

COC(=O)C=Cc1cc(NC(=O)c2cccnc2)ccc1Oc1ccc(F)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.52
▸ TSHR P16473 2/20 0.52
▸ KMT2A Q03164 5/20 0.50
▸ MEN1 O00255 3/20 0.50
▸ POLB P06746 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ MET P08581 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ RAB9A P51151 3/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ NPC1 O15118 2/20 0.47
▸ HDAC3 O15379 1/20 0.46
▸ BRAF P15056 1/20 0.46
▸ HDAC4 P56524 1/20 0.46
▸ HDAC1 Q13547 1/20 0.46
▸ HDAC7 Q8WUI4 1/20 0.46
▸ HDAC2 Q92769 1/20 0.46
▸ HDAC10 Q969S8 1/20 0.46
▸ HDAC11 Q96DB2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15065794 1.00 SMN1; SMN2 (0.52) SMN1; SMN2TSHRKMT2AMEN1POLB
SCHEMBL15068379 0.89 KMT2A (0.52) SMN1; SMN2TSHRKMT2AMEN1POLB
SCHEMBL15068380 0.89 KMT2A (0.52) SMN1; SMN2TSHRKMT2AMEN1POLB
SCHEMBL15065363 0.83 SCN9A (0.50) KMT2AMEN1POLBKDM4EL3MBTL1
SCHEMBL15065361 0.83 SCN9A (0.50) KMT2AMEN1POLBKDM4EL3MBTL1
SCHEMBL15068422 0.80 SMN1; SMN2 (0.48) SMN1; SMN2TSHRKMT2AMEN1POLB
SCHEMBL15068419 0.80 SMN1; SMN2 (0.48) SMN1; SMN2TSHRKMT2AMEN1POLB
SCHEMBL15066399 0.79 CCNC (0.40) SMN1; SMN2KMT2APOLBKDM4ELMNA
SCHEMBL15065392 0.76 NPC1 (0.58) SMN1; SMN2KMT2AMEN1L3MBTL1RAB9A
SCHEMBL15065389 0.76 NPC1 (0.58) SMN1; SMN2KMT2AMEN1L3MBTL1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150045367-A1 CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 PHARMACYCLICS LLC 2015-02-12 — — US disclosed
EP-2797875-A1 CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 Pharmacyclics, Inc. (US) 2014-11-05 — — EP disclosed
WO-2013101600-A1 CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 PHARMACYCLICS, INC. (US) 2013-07-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150045367-A1 CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 HDAC8, HDAC5, HDAC7 SMN1; SMN2 1868/4885TSHR 4824/4885KMT2A 91/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback